Reports
Reports
Sale
The global flow cytometry market was valued at USD 5.29 billion in 2023, driven by the advent of artificial intelligence enabled automated systems across the globe. The market is expected to grow at a CAGR of 7.8% during the forecast period of 2024-2032, with the values likely to rise from USD 5.71 billion in 2024 to USD 10.41 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Flow cytometry is an analytical technique used to identify cells based on molecular characteristics. It is used to isolate information on specific types from different organs of the body or bodily fluids which may be difficult to separate from each other. It is widely used by researchers in immunophenotyping, cell cycle analysis, cell sorting, apoptosis, and intracellular calcium flux.
The pharmaceutical industry, tech companies, and medical diagnostics are driving explosive expansion in the field. Toxicology studies rely heavily on it since it helps investigators understand how drugs affect different cell types and how processes like cell cycle alterations and apoptosis work. It has been widely used in pharmaceutical research because of its accuracy and efficiency in assessing cell-based tests. The flow cytometry market value is impacted by significant improvements in the flow cytometer technologies, with a vision to offer improved workflows via innovation and automation. The market is driven by increasing mergers and collaborations between companies and advancements in the existing technologies for better solutions. The advent of artificial intelligence and robotics is a major driver for enhanced market value.
Rising desire for personalised treatment, new technologies, and increasing use in areas such as immunology, cancer, are all contributing to the worldwide expansion of flow cytometry. As the healthcare industry places a greater emphasis on precision medicine and biomarker identification, the demand for improved cellular analysis tools in research and clinical diagnostics is on the rise. Consequently, the demand for flow cytometry is expected to grow, with spectral flow cytometry becoming more popular for improved multiparametric analysis. Flow cytometry reagents market is growing at a substantial rate due to the rising requirement for reagents that are specifically designed to meet the needs of research and diagnostics. The market is witnessing development of high-throughput flow cytometry systems along with artificial intelligence and machine learning algorithm driven analytical tools to provide precise and accurate solutions.
Increasing Prevalence of Chronic Diseases
When it comes to analysing and quantifying cells or particles within a heterogeneous mixture, flow cytometry is a strong analytical tool. It uses optics and lasers to find and quantify features, including particle or cell size, shape, and fluorescence intensity. Since chronic diseases including cancer, diabetes, cardiovascular diseases are on the rise, flow cytometers are anticipated to witness wide applications in combating the morbidities associated with such diseases. With its adaptable software, hardware, and applications, flow cytometry is becoming an indispensable tool for studying biological systems. Its practical applications cover a wide range of scientific fields, including drug development, immunology, cancer research, stem cell studies, and microbiology.
Rising Emphasis on Drug Discovery and Development
Drug discovery and development is a primary area of attention amongst flow cytometry companies and scientists to address unmet needs of patients suffering from rare diseases. The extraordinary capacity of flow cytometry to examine varied cell types has made it a crucial instrument in the field of medication research and discovery. When it comes to understanding the biology and functional properties of specific cells, flow cytometry is indispensable, especially in the pharmaceutical industry. New bioactive drug candidates can be more easily identified and evaluated thanks to recent developments in flow cytometry, which has greatly simplified the drug discovery process. Some examples of recent developments in the field of flow cytometry include faster event detection and resolution, better cell sorting capabilities, and the ability to do high-throughput multifactorial studies.
Constant Improvements in Technology
Incorporating microfluidic technology into flow cytometry devices is a new development that aims to improve their accuracy and efficiency. This development allows for more precise analysis, which in turn opens new opportunities, likely to boost the share for flow cytometry services market in the forecast period. The integration of augmented reality (AR) technology into flow cytometer data display also represents a giant step toward better user experience. Augmented reality technology makes data interpretation more engaging and intuitive by allowing real-time interaction with complex cytometry data. Innovations like these are fuelling the flow cytometry market expansion by making devices more useful.
Preference for Eco-Friendly Flow Cytometers
Eco-friendly flow cytometers are becoming a critical part of scientific research, driven by increasing emphasis on practising sustainability. Several companies are investing in research and development of green and clean technologies, along with regulatory authorities imposing strict rules to limit electronic waste and the use of hazardous materials. The production of reusable and biodegradable flow cytometry consumables is on the rise, intended to minimise wastes. Some of the prominent eco-friendly flow cytometers include BD FACSMelody™, Sony SH800 and Cytek® Aurora among others.
Adoption of Automation for Preparing Samples
There is a rising movement in the flow cytometry industry to automate sample preparation procedures and make the entire process more efficient. Companies are investing in integrated systems to automate these processes, which will boost production and decrease the need for human oversight. The demand for automated equipment in the flow cytometry market is skyrocketing as a wide range of companies look to boost efficiency and production.
Surge in Partnerships and Acquisitions to Boost the Market Value
In January, 2024, Thermo Fisher Scientific Inc., a leading provider of analytical equipment and life sciences solutions, collaborated with C-CAMP to launch a Centre of Excellence in Bengaluru. This was done to facilitate the development of the institute. Being a centre of scientific innovation and medical research, India is witnessing an influx of foreign capital, directed towards improving the healthcare infrastructure. The partnership also offers workflow solutions for molecular biology along with research and training opportunities to upskill the medical personnel pertaining to the region. With this new collaboration, Thermo Fisher Scientific is in an excellent position to continue expanding its presence in the rapidly expanding biotechnology industry in India, which is projected to reach a value of USD 300 billion by the year 2030.
In January, 2024, Cytek Biosciences, Inc., a leading firm in the field of cell analysis solutions, signed an agreement with the Centre for Genomic Regulation (CRG) and Pompeu Fabra University (UPF) with the intention of fostering technical innovation and accelerating scientific breakthroughs in flow cytometry. As per the terms of agreement, Cytek is designated to offer new spectral cytrometry platforms along with specialised training personnel to the CRG-UPF Flow Cytometry Unit’s headquarters. Such initiatives indicate an emphasis on educating the medical professionals with latest technologies.
In January, 2024, the oncology testing services provider NeoGenomics, Inc., partnered with the artificial intelligence company ConcertAI, LLC, a frontrunner in cancer real-world evidence data analytics to develop a large scale hematological solution that utilises flow cytometry. In addition, this partnership highlights a mutual dedication of adopting sustainable alternatives and bring good to the world, both socially and environmentally. This partnership will bring about groundbreaking innovations and advancements in oncology.
New Product Launches to Offer Improved Solutions to the Patients
In June, 2023, BD launched FACSDuet TM Premium Sample Preparation System, an automated clinical flow cytometry that altered the landscape of clinical flow cytometry diagnostic sample preparation. This automated system reduces the amount of time spent manually transferring samples to the BD FACSLyricTM Clinical Flow Cytometry solution, which speeds up procedures such as washing, centrifuging, and cocktailing. The rising incidence of new product launches by key companies is likely to boost the market value of flow cytometry in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product & Services
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Reagents and Consumables to Hold a Significant Market Value
The market segmentation based on products and services is divided into instruments, reagents and consumables, solutions, and software along with services. The instruments are further divided into cell analyzers and cell sorters. In the forecast period, the market share for reagents and consumables is expected to hold a notable market share. Flow cytometry reagents are in high demand due to the increasing variety of diagnostic tests performed in hospitals and clinics around the world. These tests are used to diagnose diseases like cancer and HIV among others. Consumables, including fluorochrome conjugated antibodies, and flow cell sheath fluids play a critical role in the effectiveness and accuracy of flow cytometry. Rising adoption of eco-friendly and high-quality reagents, that help in maintaining proper instrument calibration are amongst the major factors fuelling the growth of consumables segment in the market.
Biotechnology and Pharmaceutical Companies Lead the Global Market Share Based on End Users
Based on end users, the market segmentation includes hospitals, biotechnology, and pharmaceutical companies, CROs, clinical and diagnostic labs along with research and academic institutes. Biotechnology and pharmaceutical companies are estimated to hold a notable in the forecast period. The market growth can be attributed to drug companies rapidly expanding pharmaceutical business, primarily driven by a focus on individualized therapy. Increasing application of flow cytometry in hospitals, CROs, clinical and diagnostic labs is another factor projected to fuel the market value in the forecast period. In addition, the rising demand for sophisticated analytical instruments, such as flow cytometers and consumables drives market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on regions, the market is segmented into North America, Europe, Asia Pacific, Latin America, along with Middle East and Africa. The flow cytometry is anticipated to be dominated by the North American region, owing to the presence of affluent universities, biotech enterprises, and research institutes. The United States is well-positioned to lead the North American region in flow cytometry innovation and development.
In Europe, the world-class research institutions and biotech firms in developed countries like United Kingdom, France, Italy, and Germany contribute to its significant market value. In the Asia Pacific region, the flow cytometry services market is expected to flourish driven by increased expenditure into the healthcare infrastructure, research and development, along with a diverse patient base. The availability of affordable resources along with skilled working professionals are major factors fuelling the market growth in the region.
The key features of the market report include patent analyses, funding and investment analysis, strategic initiatives by the leading key players. The major companies in the market are as follows:
Danaher Corporation
Founded in 1969 and headquartered in Washington, this company produces a variety of flow cytometry products like clinical flow cytometer, Navios EX flow cytometer, CytoFLEX nano Flow Cytometer.
Becton, Dickinson, and Company
Founded in 1897, and headquartered in New Jersey, United States, Becton, Dickinson and Company (BD) has launched a range of flow cytometry products, including BD FACSDuet, BD FACSDuet Premium, BD Horizon RealYellow and RealBlue Reagents.
SYSMEX CORPORATION
Headquartered in Japan, this company manufactures a variety of products including XF-1600, CyFlow Cube 6, CyFlow Cube 8, CyFlow Space, and PS-10.
Agilent Technologies, Inc.
California, United based Agilent Technologies was established in 1999. The company produces Agilent NovoCyte Penteon, NovoCyte Flow Cytometer. Deploying latest technologies into their equipment, the company is projected to bring advanced cytometers in the market.
Other companies in the market include Beckman Coulter, Inc., Apogee Flow Systems Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Stratedigm, Inc., DiaSorin SpA, Miltenyi Biotec, Sony Biotechnology, Inc., Nanocellect Biomedical, Inc., and Merck KGaA.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product & Services |
|
Breakup by Technology |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Flow Cytometry Market Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Flow Cytometry Market Overview
3.1 Global Flow Cytometry Market Historical Value (2017-2023)
3.2 Global Flow Cytometry Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Flow Cytometry Market Landscape*
5.1 Global Flow Cytometry: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Flow Cytometry: Product Landscape
5.2.1 Analysis by Product & Services
5.2.2 Analysis by Application
5.2.3 Analysis by Technology
6 Global Flow Cytometry Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Environmental
6.3.3 Social
6.3.4 Technological
6.3.5 Ethical
6.3.6 Legal
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Flow Cytometry Market Segmentation (2017-2032)
7.1 Global Flow Cytometry Market (2017-2032) by Product & Services
7.1.1 Market Overview
7.1.2 Instruments
7.1.2.1 Cell Sorters
7.1.2.2 Cell Analyzers
7.1.3 Reagents and Consumables
7.1.4 Solutions & Software
7.1.5 Services
7.2 Global Flow Cytometry Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 Bead-based
7.2.3 Cell-based
7.3 Global Flow Cytometry Market (2017-2032) by Application
7.3.1 Market Overview
7.3.2 Research
7.3.2.1 Cell Sorting
7.3.2.2 Immunology
7.3.2.3 Apotosis
7.3.2.4 Pharmaceutical & Biotechnology
7.3.2.5 Others
7.3.3 Clinical
7.3.3.1 Hematology
7.3.3.2 Organ Transplantation
7.3.3.3 Autoimmune Diseases
7.3.3.4 Cancer Diagnosis
7.3.4 Industrial
7.3.5 Others
7.4 Global Flow Cytometry Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Biotechnology and Pharmaceutical Companies
7.4.4 CROs
7.4.5 Clinical and Diagnostic Labs
7.4.6 Research and Academic Institutes
7.5 Global Flow Cytometry Market (2017-2032) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Flow Cytometry Market (2017-2032)
8.1 North America Flow Cytometry Market (2017-2032) by Product & Services
8.1.1 Market Overview
8.1.2 Instruments
8.1.2.1 Cell Sorters
8.1.2.2 Cell Analyzers
8.1.3 Reagents and Consumables
8.1.4 Solutions & Software
8.1.5 Services
8.2 North America Flow Cytometry Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 Bead-based
8.2.3 Cell-based
8.3 North America Flow Cytometry Market (2017-2032) by Application
8.3.1 Market Overview
8.3.2 Research
8.3.2.1 Cell Sorting
8.3.2.2 Immunology
8.3.2.3 Apotosis
8.3.2.4 Pharmaceutical & Biotechnology
8.3.2.5 Others
8.3.3 Clinical
8.3.3.1 Hematology
8.3.3.2 Organ Transplantation
8.3.3.3 Autoimmune Diseases
8.3.3.4 Cancer Diagnosis
8.3.4 Industrial
8.3.5 Others
8.4 North America Flow Cytometry Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Flow Cytometry Market (2017-2032)
9.1 Europe Flow Cytometry Market (2017-2032) by Product & Services
9.1.1 Market Overview
9.1.2 Instruments
9.1.2.1 Cell Sorters
9.1.2.2 Cell Analyzers
9.1.3 Reagents and Consumables
9.1.4 Solutions & Software
9.1.5 Services
9.2 Europe Flow Cytometry Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 Bead-based
9.2.3 Cell-based
9.3 Europe Flow Cytometry Market (2017-2032) by Application
9.3.1 Market Overview
9.3.2 Research
9.3.2.1 Cell Sorting
9.3.2.2 Immunology
9.3.2.3 Apotosis
9.3.2.4 Pharmaceutical & Biotechnology
9.3.2.5 Others
9.3.3 Clinical
9.3.3.1 Hematology
9.3.3.2 Organ Transplantation
9.3.3.3 Autoimmune Diseases
9.3.3.4 Cancer Diagnosis
9.3.4 Industrial
9.3.5 Others
9.4 Europe Flow Cytometry Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Flow Cytometry Market (2017-2032)
10.1 Asia Pacific Flow Cytometry Market (2017-2032) by Product & Services
10.1.1 Market Overview
10.1.2 Instruments
10.1.2.1 Cell Sorters
10.1.2.2 Cell Analyzers
10.1.3 Reagents and Consumables
10.1.4 Solutions & Software
10.1.5 Services
10.2 Asia Pacific Flow Cytometry Market (2017-2032) by Technology
10.2.1 Market Overview
10.2.2 Bead-based
10.2.3 Cell-based
10.3 Asia Pacific Flow Cytometry Market (2017-2032) by Application
10.3.1 Market Overview
10.3.2 Research
10.3.2.1 Cell Sorting
10.3.2.2 Immunology
10.3.2.3 Apotosis
10.3.2.4 Pharmaceutical & Biotechnology
10.3.2.5 Others
10.3.3 Clinical
10.3.3.1 Hematology
10.3.3.2 Organ Transplantation
10.3.3.3 Autoimmune Diseases
10.3.3.4 Cancer Diagnosis
10.3.4 Industrial
10.3.5 Others
10.4 Asia Pacific Flow Cytometry Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Flow Cytometry Market (2017-2032)
11.1 Latin America Flow Cytometry Market (2017-2032) by Product & Services
11.1.1 Market Overview
11.1.2 Instruments
11.1.2.1 Cell Sorters
11.1.2.2 Cell Analyzers
11.1.3 Reagents and Consumables
11.1.4 Solutions & Software
11.1.5 Services
11.2 Latin America Flow Cytometry Market (2017-2032) by Technology
11.2.1 Market Overview
11.2.2 Bead-based
11.2.3 Cell-based
11.3 Latin America Flow Cytometry Market (2017-2032) by Application
11.3.1 Market Overview
11.3.2 Research
11.3.2.1 Cell Sorting
11.3.2.2 Immunology
11.3.2.3 Apotosis
11.3.2.4 Pharmaceutical & Biotechnology
11.3.2.5 Others
11.3.3 Clinical
11.3.3.1 Hematology
11.3.3.2 Organ Transplantation
11.3.3.3 Autoimmune Diseases
11.3.3.4 Cancer Diagnosis
11.3.4 Industrial
11.3.5 Others
11.4 Latin America Flow Cytometry Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Flow Cytometry Market (2017-2032)
12.1 Middle East and Africa Flow Cytometry Market (2017-2032) by Product & Services
12.1.1 Market Overview
12.1.2 Instruments
12.1.2.1 Cell Sorters
12.1.2.2 Cell Analyzers
12.1.3 Reagents and Consumables
12.1.4 Solutions & Software
12.1.5 Services
12.2 Middle East and Africa Flow Cytometry Market (2017-2032) by Technology
12.2.1 Market Overview
12.2.2 Bead-based
12.2.3 Cell-based
12.3 Middle East and Africa Flow Cytometry Market (2017-2032) by Application
12.3.1 Market Overview
12.3.2 Research
12.3.2.1 Cell Sorting
12.3.2.2 Immunology
12.3.2.3 Apotosis
12.3.2.4 Pharmaceutical & Biotechnology
12.3.2.5 Others
12.3.3 Clinical
12.3.3.1 Hematology
12.3.3.2 Organ Transplantation
12.3.3.3 Autoimmune Diseases
12.3.3.4 Cancer Diagnosis
12.3.4 Industrial
12.3.5 Others
12.4 Middle East and Africa Flow Cytometry Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership and Collaborations
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia-Pacific
17.1.5 Market Share Analysis: Others
17.2 Danaher Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Becton, Dickinson, and Company
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Beckman Coulter, Inc .
17.4.1 Product Portfolio
17.4.2 Demographic Reach and Achievements
17.4.3 Mergers and Acquisitions
17.4.4 Certifications
17.5 SYSMEX CORPORATION
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Agilent Technologies , Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Apogee Flow Systems Ltd .
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Bio-Rad Laboratories, Inc .
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Thermo Fisher Scientific, Inc .
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Stratedigm, Inc .
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 DiaSorin S.p .A.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Miltenyi Biotec
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Sony Biotechnology, Inc .
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Merck KGaA
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Nanocellect Biomedical, Inc .
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Flow Cytometry Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.